Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2026)

Abeona Therapeutics' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 54.11% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $137.9 million (down 9.39% YoY), while the FY2025 annual figure was $167.3 million, up 39.16% from the prior year.
• Change in Acquisitions & Divestments was $24.9 million for Q1 2026 at Abeona Therapeutics, up from $14.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $71.8 million in Q3 2025 to a low of $8.7 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $24.5 million across 5 years, with a median of $17.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments sank 65.32% in 2022, then jumped 231.3% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $8.9 million in 2022, then jumped by 67.46% to $15.0 million in 2023, then surged by 100.22% to $30.0 million in 2024, then sank by 50.26% to $14.9 million in 2025, then jumped by 67.04% to $24.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $24.9 million (Q1 2026), $14.9 million (Q4 2025), and $71.8 million (Q3 2025), per Business Quant data.